Prenalterol

CAS: 57526-81-5

Ref. 3D-FP27157

Produktinformation

• Name: Prenalterol
• Synonyme: 4-[(2S)-2-Hydroxy-3-[(1-methylethyl)amino]propoxy]phenol(-)-Prenalterol(S)-Prenalterol, (-)-(S)-1-(p-Hydroxyphenoxy)-3-(isopropylamino)-2-propanol, (S)-4-(2-Hydroxy-3-(isopropylamino)propoxy)phenol, (S)-4-[2-Hydroxy-3-[(1-methylethyl)amino]propoxy]phenol, (S)-Prenalterol, 260-791-5, 4-[(2S)-2-Hydroxy-3-[(1-methylethyl)amino]propoxy]phenol, 4-[2-Hydroxy-3-(Propan-2-Ylamino)Propoxy]Phenol, 4-{[(2S)-2-hydroxy-3-(propan-2-ylamino)propyl]oxy}phenol, Cgp 7760B, H 133/22, Hyprenan, Phenol, 4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)-, (S)-, Phenol, 4-[(2S)-2-hydroxy-3-[(1-methylethyl)amino]propoxy]-, S-Varbian, phenol, 4-[[(2S)-2-hydroxy-3-[(1-methylethyl)amino]propyl]oxy]-
• CAS: 57526-81-5

Beschreibung

Prenalterol is a drug that can be used to treat congestive heart failure and high blood pressure. It belongs to the class of 2-adrenergic receptor agonists, which are drugs that stimulate the sympathetic nervous system. Prenalterol has been shown to have a positive effect on the cardiovascular system by increasing cardiac output. This drug also has an anti-inflammatory effect, which may be due to its ability to inhibit protein synthesis genes in cells. Prenalterol has also been shown to reduce post-myocardial infarction remodeling by reducing myocardial fibrosis, although it does not affect the incidence of myocardial infarcts.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 225.28 g/mol
• Formel: C₁₂H₁₉NO₃
• Reinheit: Min. 95%
• Farbe/Form: White Powder